Exact Mass: 766.287713
Exact Mass Matches: 766.287713
Found 33 metabolites which its exact mass value is equals to given mass value 766.287713,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Grazoprevir
(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.0^{3,12.0^{5,10.0^{18,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide
C38H50N6O9S (766.3359810000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate
[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate
rossicaside G|trans-p-coumaryl alcohol-O-beta-D-glucopyranosyl(1?4)-alpha-L-rhamnopyranosyl(1?3)(4-O-trans-p-coumaryl)-beta-D-glucopyranoside
rossicaside G|trans-p-coumaryl alcohol-O-beta-D-glucopyranosyl(1?4)-alpha-L-rhamnopyranosyl(1?3)(4-O-trans-p-coumaryl)-beta-D-glucopyranoside
rossicaside H|trans-p-coumaryl alcohol-O-beta-D-glucopyranosyl(1?4)-alpha-L-rhamnopyranosyl(1?3)(6-O-trans-p-coumaryl)-beta-D-glucopyranoside
rossicaside H|trans-p-coumaryl alcohol-O-beta-D-glucopyranosyl(1?4)-alpha-L-rhamnopyranosyl(1?3)(6-O-trans-p-coumaryl)-beta-D-glucopyranoside
[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate_major
[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate_major
[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate_1.4\\%
[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate_1.4\\%
4-(4-{4-[(6-O-Acetyl-?-D-glucopyranosyl)oxy]-3-methoxyphenyl}tetrahydro-1H,3H-furo[3,4-c]furan-1-yl)-2-methoxyphenyl 6-O-acetyl-?-D-glucopyranoside
4-(4-{4-[(6-O-Acetyl-?-D-glucopyranosyl)oxy]-3-methoxyphenyl}tetrahydro-1H,3H-furo[3,4-c]furan-1-yl)-2-methoxyphenyl 6-O-acetyl-?-D-glucopyranoside
MK-5172
Grazoprevir
C38H50N6O9S (766.3359810000001)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
3,3-[5,5-Bis[3-(4-pyridinyl)phenyl][1,1:3,1:3,1-quaterphenyl]-3,3-diyl]bispyridine
3,3-[5,5-Bis[3-(4-pyridinyl)phenyl][1,1:3,1:3,1-quaterphenyl]-3,3-diyl]bispyridine
(1S,4S,7R,8S,11S,15S,18S,21R,22S,25S)-11-benzyl-4-[(2S)-butan-2-yl]-7,21,25-trimethyl-18-propan-2-yl-6,20-dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),19(30),26(29)-tetraene-2,9,16,23-tetrone
(1S,4S,7R,8S,11S,15S,18S,21R,22S,25S)-11-benzyl-4-[(2S)-butan-2-yl]-7,21,25-trimethyl-18-propan-2-yl-6,20-dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),19(30),26(29)-tetraene-2,9,16,23-tetrone
C37H50N8O6S2 (766.3294560000002)
{diazenediylbis[(4,1-phenylene)(6-methyl-1,3-benzothiazole-2,5-diyl)methylenesulfanediyl]}bis[(dimethylamino)-N,N-dimethylmethaniminium]
{diazenediylbis[(4,1-phenylene)(6-methyl-1,3-benzothiazole-2,5-diyl)methylenesulfanediyl]}bis[(dimethylamino)-N,N-dimethylmethaniminium]
methyl 2-(2,5-dimethoxy-2,5-dihydrofuran-3-yl)-6a,10b-dimethyl-4-oxo-6-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
methyl 2-(2,5-dimethoxy-2,5-dihydrofuran-3-yl)-6a,10b-dimethyl-4-oxo-6-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
1-[2-({2,6-dihydroxy-4-methoxy-3-[3-(4-methoxyphenyl)propanoyl]phenyl}(2,4,5-trihydroxyphenyl)methyl)-4-hydroxy-6-methoxy-2,3-dihydro-1-benzofuran-5-yl]-3-(4-methoxyphenyl)propan-1-one
1-[2-({2,6-dihydroxy-4-methoxy-3-[3-(4-methoxyphenyl)propanoyl]phenyl}(2,4,5-trihydroxyphenyl)methyl)-4-hydroxy-6-methoxy-2,3-dihydro-1-benzofuran-5-yl]-3-(4-methoxyphenyl)propan-1-one
6-[3-(acetyloxy)-2-[2-(hydroxymethyl)-2-methyl-5-oxooxolan-3-yl]-5-methoxy-5-oxopentan-2-yl]-5-(formyloxy)-7a-hydroxy-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-3a-methyl-7-methylidene-1-oxo-tetrahydro-2h-inden-4-yl 3-hydroxy-4-methylhexanoate
6-[3-(acetyloxy)-2-[2-(hydroxymethyl)-2-methyl-5-oxooxolan-3-yl]-5-methoxy-5-oxopentan-2-yl]-5-(formyloxy)-7a-hydroxy-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-3a-methyl-7-methylidene-1-oxo-tetrahydro-2h-inden-4-yl 3-hydroxy-4-methylhexanoate